Intravenous drug use (IVDU) and HIV-1 infections are two linked global health crises since needle sharing is a well-recognized mode of HIV-1 transmission. Drugs of abuse accelerate the incidence and progression of HIV- 1-associated neurological disorders (HAND). Drug-abusing HIV-1 positive individuals exhibit more severe cognitive impairment compared with the non-drug-abusing HIV positive counterparts. Cocaine, often abused by HIV-infected patients, has been suggested to worsen HIV-associated CNS disease. Although antiretroviral therapy (ART) has diminished the incidence of HIV-1-associated dementia (HAD), milder forms of neurological disease do persist. Increased survival rates resulting from ART therapy usage have led to an increase in the prevalence of HAND. Despite the recognized impact of the abuse of cocaine on the clinical course of HIV-1- associated brain pathology;mechanisms underlying the ability of cocaine to enhance the pathological effects of HIV-1 in the brain remain elusive. It is well-recognized that despite near complete suppression of viremia in the face of ART, early viral proteins such as HIV Tat are found lurking in tissue sites, thereby contributing to residual chronic neuroinflammation/glial activation observed in HAND. Recent studies indicate ER stress as a protective response by the cell against external injury/insult. Our preliminary studies the indicate role of ER stress in HIV Tat-mediated upregulation of GFAP (astrogliosis) in primary rat astrocytes. Whether cocaine cooperates with HIV Tat to synergistically induce astrogliosis via the ER stress pathway, remains unknown. We hypothesize that HIV Tat &cocaine via the induction of endoplasmic reticulum (ER) stress, co-operate to enhance astrocyte activation &apoptosis, hallmark features of HAND. This will be tested via three specific aims: a) To examine the role of ER stress in HIV Tat &/or cocaine mediated upregulation of astrogliosis (upergulation of GFAP) in both rat and human primary astrocytes, b) To investigate the signaling pathways involved in HIV Tat &/or cocaine mediated enhancement of astrogliosis and c) To test in vivo the therapeutic potential of inhibition of ER response as an intervention strategy for ameliorating Tat &or cocaine-mediated astrogliosis in rodent models of HAND.

Public Health Relevance

Cocaine, a highly potent and addictive brain stimulant, often abused by HIV-infected patients, is known to exacerbate HIV-associated CNS disease via activation of astrocytes. This application is aimed at understanding molecular mechanisms involved in the combined deleterious effects of HIV-1 and cocaine in the brain with the ultimate goal of understanding the role of endoplasmic reticulum stress proteins. Unraveling these pathways will set a stage for future development of therapeutics aimed at mitigating astrocyte activation, a hallmark feature of neurodegenerative disorders including HIV-associated neurocognitive disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA036157-01
Application #
8584875
Study Section
Special Emphasis Panel (ZDA1-GXM-A (08))
Program Officer
Frankenheim, Jerry
Project Start
2013-07-01
Project End
2018-03-31
Budget Start
2013-07-01
Budget End
2014-03-31
Support Year
1
Fiscal Year
2013
Total Cost
$376,250
Indirect Cost
$126,250
Name
University of Nebraska Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Buch, Shilpa (2014) Growth factor signaling: implications for disease & therapeutics. J Neuroimmune Pharmacol 9:65-8
Duan, Ming; Yao, Honghong; Cai, Yu et al. (2014) HIV-1 Tat disrupts CX3CL1-CX3CR1 axis in microglia via the NF-?BYY1 pathway. Curr HIV Res 12:189-200
Yao, Honghong; Ma, Rong; Yang, Lu et al. (2014) MiR-9 promotes microglial activation by targeting MCPIP1. Nat Commun 5:4386
Niu, Fang; Yao, Honghong; Zhang, Wenting et al. (2014) Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. J Neurosci 34:11812-25